478 related articles for article (PubMed ID: 11815963)
1. Phenotypic variation in eight extended CDKN2A germline mutation familial atypical multiple mole melanoma-pancreatic carcinoma-prone families: the familial atypical mole melanoma-pancreatic carcinoma syndrome.
Lynch HT; Brand RE; Hogg D; Deters CA; Fusaro RM; Lynch JF; Liu L; Knezetic J; Lassam NJ; Goggins M; Kern S
Cancer; 2002 Jan; 94(1):84-96. PubMed ID: 11815963
[TBL] [Abstract][Full Text] [Related]
2. Clinical and genetic analysis of 18 pancreatic carcinoma/melanoma-prone families.
Bartsch DK; Langer P; Habbe N; Matthäi E; Chaloupka B; Sina M; Hahn SA; Slater EP
Clin Genet; 2010 Apr; 77(4):333-41. PubMed ID: 20041885
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the neoplastic phenotype in the familial atypical multiple-mole melanoma-pancreatic carcinoma syndrome.
Rulyak SJ; Brentnall TA; Lynch HT; Austin MA
Cancer; 2003 Aug; 98(4):798-804. PubMed ID: 12910525
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic cancer-associated gene polymorphisms in a nation-wide cohort of p16-Leiden germline mutation carriers; a case-control study.
Potjer TP; van der Stoep N; Houwing-Duistermaat JJ; Konings IC; Aalfs CM; van den Akker PC; Ausems MG; Dommering CJ; van der Kolk LE; Maiburg MC; Spruijt L; Wagner A; Vasen HF; Hes FJ
BMC Res Notes; 2015 Jun; 8():264. PubMed ID: 26111702
[TBL] [Abstract][Full Text] [Related]
5. Well-differentiated Pancreatic Neuroendocrine Tumor in a Patient With Familial Atypical Multiple Mole Melanoma Syndrome (FAMMM).
Noë M; Hackeng WM; de Leng WWJ; Vergeer M; Vleggaar FP; Morsink FHM; Wood LD; Hruban RH; Offerhaus GJA; Brosens LAA
Am J Surg Pathol; 2019 Sep; 43(9):1297-1302. PubMed ID: 31261289
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the
Middlebrooks CD; Stacey ML; Li Q; Snyder C; Shaw TG; Richardson-Nelson T; Rendell M; Ferguson C; Silberstein P; Casey MJ; Bailey-Wilson JE; Lynch HT
Cancer Res; 2019 Jun; 79(11):2992-3000. PubMed ID: 30967399
[TBL] [Abstract][Full Text] [Related]
7. Head and neck squamous cell carcinoma in FAMMM syndrome.
Vinarsky V; Fine RL; Assaad A; Qian Y; Chabot JA; Su GH; Frucht H
Head Neck; 2009 Nov; 31(11):1524-7. PubMed ID: 19360740
[TBL] [Abstract][Full Text] [Related]
8. Familial pancreatic carcinoma in Jews.
Lynch HT; Deters CA; Lynch JF; Brand RE
Fam Cancer; 2004; 3(3-4):233-40. PubMed ID: 15516847
[TBL] [Abstract][Full Text] [Related]
9. Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16-Leiden).
Vasen HF; Gruis NA; Frants RR; van Der Velden PA; Hille ET; Bergman W
Int J Cancer; 2000 Sep; 87(6):809-11. PubMed ID: 10956390
[TBL] [Abstract][Full Text] [Related]
10. Familial atypical multiple mole melanoma (FAMMM) syndrome: history, genetics, and heterogeneity.
Lynch HT; Shaw TG
Fam Cancer; 2016 Jul; 15(3):487-91. PubMed ID: 26892865
[TBL] [Abstract][Full Text] [Related]
11. Development of esophageal squamous cell cancer in patients with FAMMM syndrome: Two clinical reports.
van der Wilk BJ; Noordman BJ; Atmodimedjo PN; Dinjens WNM; Laheij RJF; Wagner A; Wijnhoven BPL; van Lanschot JJB
Eur J Med Genet; 2020 Mar; 63(3):103840. PubMed ID: 31923587
[TBL] [Abstract][Full Text] [Related]
12. The absence of multiple atypical nevi in germline CDKN2A mutations: Comment on "Hereditary melanoma: Update on syndromes and management: Genetics of familial atypical multiple mole melanoma syndrome".
Ipenburg NA; Gruis NA; Bergman W; van Kester MS
J Am Acad Dermatol; 2016 Oct; 75(4):e157. PubMed ID: 27646763
[No Abstract] [Full Text] [Related]
13. Familial melanoma; CDKN2A and beyond.
Gruis NA; van der Velden PA; Bergman W; Frants RR
J Investig Dermatol Symp Proc; 1999 Sep; 4(1):50-4. PubMed ID: 10537008
[TBL] [Abstract][Full Text] [Related]
14. [From gene to disease; from p16 to melanoma].
Gruis NA; Bergman W
Ned Tijdschr Geneeskd; 2000 Oct; 144(44):2100-2. PubMed ID: 11103670
[TBL] [Abstract][Full Text] [Related]
15. Multiple primary melanoma revisited.
Blackwood MA; Holmes R; Synnestvedt M; Young M; George C; Yang H; Elder DE; Schuchter LM; Guerry D; Ganguly A
Cancer; 2002 Apr; 94(8):2248-55. PubMed ID: 12001124
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic cancer and the FAMMM syndrome.
Lynch HT; Fusaro RM; Lynch JF; Brand R
Fam Cancer; 2008; 7(1):103-12. PubMed ID: 17992582
[TBL] [Abstract][Full Text] [Related]
17. Hereditary cancer syndrome diagnosis: molecular genetic clues and cancer control.
Lynch HT; Fusaro RM; Lynch JF
Future Oncol; 2007 Apr; 3(2):169-81. PubMed ID: 17381417
[TBL] [Abstract][Full Text] [Related]
18. Swedish CDKN2A mutation carriers do not present the atypical mole syndrome phenotype.
Nielsen K; Harbst K; Måsbäck A; Jönsson G; Borg A; Olsson H; Ingvar C
Melanoma Res; 2010 Aug; 20(4):266-72. PubMed ID: 20526219
[TBL] [Abstract][Full Text] [Related]
19. Genetic counselling and high-penetrance susceptibility gene analysis reveal the novel CDKN2A p.D84V (c.251A>T) mutation in melanoma-prone families from Italy.
Borroni RG; Manganoni AM; Grassi S; Grasso M; Diegoli M; Giorgianni C; Favalli V; Pavoni L; Cespa M; Arbustini E
Melanoma Res; 2017 Apr; 27(2):97-103. PubMed ID: 28060055
[TBL] [Abstract][Full Text] [Related]
20. Undifferentiated carcinoma with osteoclastic giant cells (UCOCGC) of the pancreas associated with the familial atypical multiple mole melanoma syndrome (FAMMM).
Koorstra JB; Maitra A; Morsink FH; Drillenburg P; ten Kate FJ; Hruban RH; Offerhaus JA
Am J Surg Pathol; 2008 Dec; 32(12):1905-9. PubMed ID: 18813118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
